![](/img/cover-not-exists.png)
The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease
Marina S. Boukhvalova, Gregory A. Prince, Layla Soroush, Dolores C. Harrigan, Stefanie N. Vogel, Jorge C.G. BlancoVolume:
24
Year:
2006
Language:
english
DOI:
10.1016/j.vaccine.2006.03.064
File:
PDF, 641 KB
english, 2006